Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cadherin binding	SPTBN1 OBSCN APC RDX MACF1 TNKS1BP1 PPL	6.11e-05	339	59	7	GO:0045296
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH1 CACNB2 HAUS6 MYH13 BRCA2 SPTBN1 OBSCN APC LMTK2 RDX MACF1 RP1	7.36e-05	1099	59	12	GO:0008092
GeneOntologyMolecularFunction	cell adhesion molecule binding	ECM2 SPTBN1 OBSCN APC RDX MACF1 TNKS1BP1 PPL	3.60e-04	599	59	8	GO:0050839
GeneOntologyMolecularFunction	actin filament binding	MYH1 CACNB2 MYH13 SPTBN1 MACF1	5.52e-04	227	59	5	GO:0051015
GeneOntologyMolecularFunction	calmodulin binding	MYH1 MYH13 SPTBN1 OBSCN PCNT	5.86e-04	230	59	5	GO:0005516
GeneOntologyCellularComponent	supramolecular fiber	MYH1 HAUS6 MYH13 SYNJ1 CEP162 SPTBN1 OBSCN APC MACF1 RP1 GGPS1 PPL PCNT	1.95e-05	1179	59	13	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	MYH1 HAUS6 MYH13 SYNJ1 CEP162 SPTBN1 OBSCN APC MACF1 RP1 GGPS1 PPL PCNT	2.09e-05	1187	59	13	GO:0099081
GeneOntologyCellularComponent	myosin filament	MYH1 MYH13 OBSCN	4.70e-05	25	59	3	GO:0032982
GeneOntologyCellularComponent	A band	MYH1 SPTBN1 OBSCN	4.28e-04	52	59	3	GO:0031672
GeneOntologyCellularComponent	microtubule	HAUS6 SYNJ1 CEP162 APC MACF1 RP1 PCNT	7.30e-04	533	59	7	GO:0005874
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH13	9.16e-04	16	59	2	GO:0005859
GeneOntologyCellularComponent	myofibril	MYH1 MYH13 SPTBN1 OBSCN GGPS1	1.03e-03	273	59	5	GO:0030016
GeneOntologyCellularComponent	interstitial matrix	ECM2 NAV2	1.04e-03	17	59	2	GO:0005614
GeneOntologyCellularComponent	cell-cell junction	MYH1 OBSCN APC RDX TNKS1BP1 PPL PDZD2	1.33e-03	591	59	7	GO:0005911
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 MYH13 SPTBN1 OBSCN GGPS1	1.35e-03	290	59	5	GO:0043292
Domain	ETS_PEA3_N	ETV1 ETV5	2.64e-05	3	56	2	PF04621
Domain	ETS_PEA3_N	ETV1 ETV5	2.64e-05	3	56	2	IPR006715
Domain	Spectrin_repeat	SPTBN1 MACF1 PPL	8.83e-05	29	56	3	IPR002017
Domain	Spectrin/alpha-actinin	SPTBN1 MACF1 PPL	1.19e-04	32	56	3	IPR018159
Domain	SPEC	SPTBN1 MACF1 PPL	1.19e-04	32	56	3	SM00150
Domain	Plectin_repeat	MACF1 PPL	1.84e-04	7	56	2	IPR001101
Domain	Plectin	MACF1 PPL	1.84e-04	7	56	2	PF00681
Domain	PLEC	MACF1 PPL	1.84e-04	7	56	2	SM00250
Domain	Myosin_N	MYH1 MYH13	9.04e-04	15	56	2	PF02736
Domain	Myosin_N	MYH1 MYH13	9.04e-04	15	56	2	IPR004009
Domain	CH	SPTBN1 NAV2 MACF1	9.78e-04	65	56	3	SM00033
Domain	-	RABGAP1L SPTBN1 OBSCN GRB10 RDX APBB1IP	1.09e-03	391	56	6	2.30.29.30
Domain	CH	SPTBN1 NAV2 MACF1	1.21e-03	70	56	3	PF00307
Domain	IQ	MYH1 MYH13 OBSCN	1.26e-03	71	56	3	PF00612
Domain	-	SPTBN1 NAV2 MACF1	1.26e-03	71	56	3	1.10.418.10
Domain	Myosin_tail_1	MYH1 MYH13	1.31e-03	18	56	2	PF01576
Domain	Myosin_tail	MYH1 MYH13	1.31e-03	18	56	2	IPR002928
Domain	CH	SPTBN1 NAV2 MACF1	1.37e-03	73	56	3	PS50021
Domain	Myosin-like_IQ_dom	MYH1 MYH13	1.46e-03	19	56	2	IPR027401
Domain	-	MYH1 MYH13	1.46e-03	19	56	2	4.10.270.10
Domain	CH-domain	SPTBN1 NAV2 MACF1	1.48e-03	75	56	3	IPR001715
Domain	PH_dom-like	RABGAP1L SPTBN1 OBSCN GRB10 RDX APBB1IP	1.68e-03	426	56	6	IPR011993
Domain	IQ	MYH1 MYH13 OBSCN	1.85e-03	81	56	3	SM00015
Domain	Actinin_actin-bd_CS	SPTBN1 MACF1	2.15e-03	23	56	2	IPR001589
Domain	Spectrin	SPTBN1 MACF1	2.15e-03	23	56	2	PF00435
Domain	ACTININ_2	SPTBN1 MACF1	2.15e-03	23	56	2	PS00020
Domain	ACTININ_1	SPTBN1 MACF1	2.15e-03	23	56	2	PS00019
Domain	IQ_motif_EF-hand-BS	MYH1 MYH13 OBSCN	2.49e-03	90	56	3	IPR000048
Domain	IQ	MYH1 MYH13 OBSCN	2.74e-03	93	56	3	PS50096
Domain	ETS_DOMAIN_1	ETV1 ETV5	3.17e-03	28	56	2	PS00345
Domain	ETS_DOMAIN_2	ETV1 ETV5	3.17e-03	28	56	2	PS00346
Domain	ETS	ETV1 ETV5	3.17e-03	28	56	2	SM00413
Domain	Ets_dom	ETV1 ETV5	3.17e-03	28	56	2	IPR000418
Domain	ETS_DOMAIN_3	ETV1 ETV5	3.17e-03	28	56	2	PS50061
Domain	Ets	ETV1 ETV5	3.17e-03	28	56	2	PF00178
Domain	P-loop_NTPase	DDX19B MYH1 CACNB2 MYH13 ERCC6L NAV2 ARL15 NLRC4	3.59e-03	848	56	8	IPR027417
Domain	RA	GRB10 APBB1IP	3.88e-03	31	56	2	SM00314
Domain	PH	SPTBN1 OBSCN GRB10 APBB1IP	4.91e-03	229	56	4	PF00169
Domain	RA	GRB10 APBB1IP	5.21e-03	36	56	2	PF00788
Domain	SAM/pointed	KIDINS220 SAMD4B PPFIA3	5.22e-03	117	56	3	IPR013761
Domain	RA	GRB10 APBB1IP	5.50e-03	37	56	2	PS50200
Domain	Myosin_head_motor_dom	MYH1 MYH13	5.79e-03	38	56	2	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH13	5.79e-03	38	56	2	PS51456
Domain	Myosin_head	MYH1 MYH13	5.79e-03	38	56	2	PF00063
Domain	MYSc	MYH1 MYH13	5.79e-03	38	56	2	SM00242
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DDX19B SYNJ1 ERCC6L RABEP1 CEP162 RABGAP1L SAMD4B SPTBN1 CCDC138 APC NAV2 LMTK2 GRB10 MACF1 TNKS1BP1	1.35e-11	861	60	15	36931259
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CASP8AP2 ANKFY1 SYNJ1 NAV2 MACF1 TNKS1BP1 PPFIA3 MED13L PCNT	1.88e-10	225	60	9	12168954
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	TRIM33 CASP8AP2 RMI1 BRCA2 SYNJ1 RBM33 RABEP1 APC MACF1 TNKS1BP1 CLSPN PCNT	3.26e-10	588	60	12	38580884
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PPP1R7 DLGAP1 CACNB2 ANKFY1 SYNJ1 RABEP1 SPTBN1 APC RDX MACF1 PPFIA3 SIPA1 TOP3B PCNT	7.53e-10	963	60	14	28671696
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	CASP8AP2 HAUS6 ANKFY1 BRCA2 SYNJ1 RABEP1 APC TNKS1BP1 PCNT	4.13e-08	418	60	9	34709266
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	RABEP1 SPTBN1 APC MACF1 TNKS1BP1 SIPA1 PPL PCNT	1.95e-07	360	60	8	33111431
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ANKFY1 KIDINS220 RABGAP1L GRB10 MACF1 MED13L PCNT PDZD2	4.94e-07	407	60	8	12693553
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	KIDINS220 RABEP1 CCDC138 APC MACF1 TNKS1BP1	1.67e-06	209	60	6	36779422
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	MYH13 RBM33 SPTBN1 OBSCN NAV2 RP1 NCLN TOP3B	2.19e-06	497	60	8	36774506
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SYNJ1 OBSCN NAV2 LMTK2 GRB10 TNKS1BP1 MED13L NCLN TOP3B PLXNA1 PCNT	2.61e-06	1105	60	11	35748872
Pubmed	Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.	BRCA2 APC	2.93e-06	2	60	2	11215675
Pubmed	APC, MYH, and the correlation genotype-phenotype in colorectal polyposis.	MYH1 APC	2.93e-06	2	60	2	19169759
Pubmed	Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltration.	APC NLRC4	2.93e-06	2	60	2	38652550
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	PPP1R7 HAUS6 CCDC138 APC CLSPN TOP3B	3.90e-06	242	60	6	34011540
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	PPP1R7 DLGAP1 CACNB2 SYNJ1 SPTBN1 MACF1	4.81e-06	251	60	6	27507650
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PPP1R7 DLGAP1 CACNB2 KIDINS220 SYNJ1 SPTBN1 APC RDX MACF1 TNKS1BP1 PPFIA3 SIPA1	5.04e-06	1431	60	12	37142655
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	KIDINS220 SYNJ1 SPTBN1 NAV2 RDX MACF1 TNKS1BP1 PPL	5.62e-06	565	60	8	25468996
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TRIM33 HAUS6 KIDINS220 MYH13 CEP162 APC ARL15 CLSPN PPL	7.07e-06	777	60	9	35844135
Pubmed	ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.	ETV1 ETV5	8.77e-06	3	60	2	22425584
Pubmed	PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro.	ETV1 ETV5	8.77e-06	3	60	2	12871699
Pubmed	Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.	ETV1 ETV5	8.77e-06	3	60	2	25203299
Pubmed	The role of Pea3 group transcription factors in esophageal squamous cell carcinoma.	ETV1 ETV5	8.77e-06	3	60	2	21689625
Pubmed	Expression patterns of the Ets transcription factors from the PEA3 group during early stages of mouse development.	ETV1 ETV5	8.77e-06	3	60	2	11578874
Pubmed	Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5.	ETV1 ETV5	8.77e-06	3	60	2	28161714
Pubmed	The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.	BRCA2 APC	8.77e-06	3	60	2	11466700
Pubmed	Differential expression patterns of the PEA3 group transcription factors through murine embryonic development.	ETV1 ETV5	8.77e-06	3	60	2	9285689
Pubmed	Identification of targets for calcium signaling through the copine family of proteins. Characterization of a coiled-coil copine-binding motif.	CEP162 SPTBN1 RDX	1.09e-05	25	60	3	12522145
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TRIM33 RMI1 BRCA2 ERCC6L RDX TNKS1BP1 LCN1	1.14e-05	444	60	7	34795231
Pubmed	Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.	NAV2 MACF1 PPFIA3	1.39e-05	27	60	3	19026994
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH13	1.75e-05	4	60	2	10388558
Pubmed	The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity.	ETV1 ETV5	1.75e-05	4	60	2	20062082
Pubmed	Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.	BRCA2 APC	1.75e-05	4	60	2	35205366
Pubmed	β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1.	ETV1 ETV5	1.75e-05	4	60	2	26627735
Pubmed	ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.	ETV1 ETV5	1.75e-05	4	60	2	28408625
Pubmed	Pea3 transcription factor family members Etv4 and Etv5 mediate retrograde signaling and axonal growth of DRG sensory neurons in response to NGF.	ETV1 ETV5	1.75e-05	4	60	2	24089499
Pubmed	A human MAP kinase interactome.	CASP8AP2 DLGAP1 RBM33 SPTBN1 APC NAV2 MACF1	2.03e-05	486	60	7	20936779
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DLGAP1 SYNJ1 RABEP1 RABGAP1L SPTBN1 APC LMTK2 MACF1 PPFIA3 NCLN	2.32e-05	1139	60	10	36417873
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	PPP1R7 ANKFY1 RABEP1 SPTBN1 OBSCN RDX MACF1	2.34e-05	497	60	7	23414517
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	HAUS6 SAMD4B APC NAV2 GRB10 TNKS1BP1 IWS1	2.53e-05	503	60	7	16964243
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HAUS6 KIDINS220 ERCC6L SPTBN1 APC RDX MACF1 TNKS1BP1	2.85e-05	708	60	8	39231216
Pubmed	MYH, OGG1, MTH1, and APC alterations involved in the colorectal tumorigenesis of Korean patients with multiple adenomas.	MYH1 APC	2.92e-05	5	60	2	17252231
Pubmed	Role of CLASP2 in microtubule stabilization and the regulation of persistent motility.	APC MACF1	2.92e-05	5	60	2	17113391
Pubmed	EB/RP gene family encodes tubulin binding proteins.	APC RP1	2.92e-05	5	60	2	10188731
Pubmed	An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.	ETV1 ETV5	2.92e-05	5	60	2	27783944
Pubmed	Structural basis for NHERF recognition by ERM proteins.	ETV5 RDX	2.92e-05	5	60	2	16615918
Pubmed	A novel role for BRCA1 in regulating breast cancer cell spreading and motility.	ETV5 RDX	2.92e-05	5	60	2	21282464
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DLGAP1 SYNJ1 SPTBN1 APC MACF1 TNKS1BP1	3.00e-05	347	60	6	17114649
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNB2 KIDINS220 RABEP1 SAMD4B OBSCN ETV1 GRB10 MACF1 ARL15 PCNT PDZD2	4.24e-05	1489	60	11	28611215
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH13	4.37e-05	6	60	2	10077619
Pubmed	Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site.	ETV1 ETV5	4.37e-05	6	60	2	15466854
Pubmed	Pbx Regulates Patterning of the Cerebral Cortex in Progenitors and Postmitotic Neurons.	LMX1A ETV1 ETV5	4.61e-05	40	60	3	26671461
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	SPTBN1 TNKS1BP1 PPL PCNT	5.30e-05	118	60	4	30979931
Pubmed	Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome.	RABEP1 SPTBN1 CLSPN	5.73e-05	43	60	3	34672947
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	DDX19B PPP1R7 ANKFY1 MYH13 SPTBN1 RDX ARL15 SLC39A5 PPL	5.81e-05	1016	60	9	19056867
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH13	6.11e-05	7	60	2	35210422
Pubmed	ErbB2 receptor controls microtubule capture by recruiting ACF7 to the plasma membrane of migrating cells.	APC MACF1	6.11e-05	7	60	2	20937854
Pubmed	The Rab5 effector Rabankyrin-5 regulates and coordinates different endocytic mechanisms.	ANKFY1 RABEP1	6.11e-05	7	60	2	15328530
Pubmed	The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.	ETV1 ETV5	6.11e-05	7	60	2	18977342
Pubmed	DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95.	DLGAP1 APC	6.11e-05	7	60	2	9286858
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DDX19B ERCC6L SPTBN1 MACF1 TNKS1BP1 APBB1IP PCNT	6.35e-05	582	60	7	20467437
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TRIM33 DLGAP1 SYNJ1 RABEP1 SPTBN1 APC RDX MACF1 MED13L PCNT	6.42e-05	1285	60	10	35914814
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TRIM33 HAUS6 ERCC6L RBM33 SAMD4B GRB10 TNKS1BP1 CLSPN IWS1	6.84e-05	1038	60	9	26673895
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PPP1R7 CEP162 SPTBN1 CCDC138 LMTK2 PPFIA3 TOP3B PCNT IWS1	7.42e-05	1049	60	9	27880917
Pubmed	Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling.	APC PCNT	8.14e-05	8	60	2	29170395
Pubmed	COP1 is a tumour suppressor that causes degradation of ETS transcription factors.	ETV1 ETV5	8.14e-05	8	60	2	21572435
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	HAUS6 KIDINS220 RBM33 APC MACF1	9.26e-05	263	60	5	34702444
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CACNB2 SYNJ1 CEP162 SPTBN1 OBSCN APC LMTK2 MACF1 PCNT	9.52e-05	1084	60	9	11544199
Pubmed	Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes.	RMI1 BRCA2	1.05e-04	9	60	2	19861517
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	PPP1R7 HAUS6 BRCA2 SYNJ1 CEP162 CCDC138 APC PCNT	1.05e-04	853	60	8	28718761
Pubmed	The SWI/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-β signaling.	RDX LCN1 LCN1P1	1.20e-04	55	60	3	35945219
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	DLGAP1 CACNB2 SYNJ1 SPTBN1 MACF1	1.26e-04	281	60	5	28706196
Pubmed	RAS/ERK signaling controls proneural genetic programs in cortical development and gliomagenesis.	ETV1 ETV5	1.31e-04	10	60	2	24501358
Pubmed	EB1 acetylation by P300/CBP-associated factor (PCAF) ensures accurate kinetochore-microtubule interactions in mitosis.	APC MACF1	1.31e-04	10	60	2	23001180
Pubmed	Laminar patterning in the developing neocortex by temporally coordinated fibroblast growth factor signaling.	ETV1 ETV5	1.31e-04	10	60	2	15470137
Pubmed	The chromatin remodelling factor Chd7 protects auditory neurons and sensory hair cells from stress-induced degeneration.	LMX1A SPTBN1	1.31e-04	10	60	2	34732824
Pubmed	Expression of dopamine pathway genes in the midbrain is independent of known ETS transcription factor activity.	ETV1 ETV5	1.59e-04	11	60	2	20610757
Pubmed	Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors.	SPTBN1 MACF1	1.59e-04	11	60	2	39256359
Pubmed	Emx2 patterns the neocortex by regulating FGF positional signaling.	ETV1 ETV5	1.59e-04	11	60	2	12872126
Pubmed	Coordination of epithelial branching and salivary gland lumen formation by Wnt and FGF signals.	ETV1 ETV5	1.59e-04	11	60	2	21806977
Pubmed	Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.	ETV1 ETV5	1.59e-04	11	60	2	28827401
Pubmed	Gene expression profiling identifies eleven DNA repair genes down-regulated during mouse neural crest cell migration.	ERCC6L CLSPN	1.59e-04	11	60	2	21425081
Pubmed	TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair.	CASP8AP2 BRCA2	1.59e-04	11	60	2	35061896
Pubmed	The adenomatous polyposis coli protein is an essential regulator of radial glial polarity and construction of the cerebral cortex.	APC PCNT	1.59e-04	11	60	2	19146812
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	SYNJ1 SPTBN1 APC RDX TOP3B IWS1	1.69e-04	475	60	6	31040226
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	DDX19B RMI1 RABEP1 LMTK2 MACF1 PCNT	1.81e-04	481	60	6	28190767
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	DDX19B ANKFY1 OBSCN TNKS1BP1 LCN1	1.82e-04	304	60	5	32235678
Pubmed	Mouse models in tumor suppression.	BRCA2 APC	1.91e-04	12	60	2	9917000
Pubmed	Nubp2 is required for cranial neural crest survival in the mouse.	ETV1 ETV5	1.91e-04	12	60	2	31733190
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	HAUS6 SYNJ1 ERCC6L RABEP1 RDX MACF1 TNKS1BP1 PCNT	1.95e-04	934	60	8	33916271
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ANKFY1 LMX1A ETV1 ETV5 MACF1 PLXNA1 ZBBX	2.15e-04	709	60	7	22988430
Pubmed	Role of Fgf8 signalling in the specification of rostral Cajal-Retzius cells.	ETV1 ETV5	2.26e-04	13	60	2	20040495
Pubmed	Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool.	CEP162 PCNT	2.26e-04	13	60	2	17920017
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	SPTBN1 MACF1 LCN1 SIPA1 PPL	2.55e-04	327	60	5	31409639
Pubmed	Analysis of candidate genes in occurrence and growth of colorectal adenomas.	MYH1 APC	2.63e-04	14	60	2	19888426
Pubmed	Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development.	ETV1 ETV5	2.63e-04	14	60	2	20215346
Pubmed	Altered proliferative ability of neuronal progenitors in PlexinA1 mutant mice.	ETV1 PLXNA1	2.63e-04	14	60	2	25975775
Pubmed	Lmx1a is an activator of Rgs4 and Grb10 and is responsible for the correct specification of rostral and medial mdDA neurons.	LMX1A GRB10	2.63e-04	14	60	2	23106268
Pubmed	Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.	ETV1 ETV5	2.63e-04	14	60	2	14635793
Pubmed	Tagging genes with cassette-exchange sites.	RABGAP1L NAV2 MACF1 ARL15 PLXNA1	2.85e-04	335	60	5	15741177
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TRIM33 CASP8AP2 CEP162 NAV2 LMTK2 TNKS1BP1	3.01e-04	529	60	6	14621295
Interaction	PHF21A interactions	CASP8AP2 HAUS6 ANKFY1 MYH13 BRCA2 SYNJ1 RABEP1 RABGAP1L APC TNKS1BP1 PCNT	3.99e-09	343	59	11	int:PHF21A
Interaction	YWHAH interactions	DLGAP1 SYNJ1 ERCC6L RABEP1 CEP162 RABGAP1L SAMD4B SPTBN1 CCDC138 APC NAV2 LMTK2 GRB10 MACF1 TNKS1BP1 SIPA1 PCNT	9.67e-09	1102	59	17	int:YWHAH
Interaction	PFN1 interactions	ANKFY1 KIDINS220 SYNJ1 RABEP1 RABGAP1L SPTBN1 APC RDX MACF1 TNKS1BP1 APBB1IP PCNT	2.25e-08	509	59	12	int:PFN1
Interaction	PCNT interactions	ANKFY1 CEP162 SPTBN1 CCDC138 RDX MACF1 TOP3B PCNT	4.88e-07	241	59	8	int:PCNT
Interaction	EZR interactions	TRIM33 HAUS6 KIDINS220 MYH13 SYNJ1 RABEP1 APC RDX MACF1 TNKS1BP1 PPL	5.11e-07	553	59	11	int:EZR
Interaction	NIN interactions	TRIM33 HAUS6 MYH13 BRCA2 CEP162 SAMD4B CCDC138 APC PCNT	9.37e-07	359	59	9	int:NIN
Interaction	YWHAG interactions	DDX19B DLGAP1 SYNJ1 ERCC6L RABEP1 CEP162 RABGAP1L SAMD4B SPTBN1 APC NAV2 LMTK2 GRB10 MACF1 SIPA1	2.09e-06	1248	59	15	int:YWHAG
Interaction	USP7 interactions	PPP1R7 TRIM33 DLGAP1 MYH13 ERCC6L SPTBN1 ETV1 APC NAV2 MACF1 FBXO39 CLSPN TOP3B PPL ZBBX	3.91e-06	1313	59	15	int:USP7
Interaction	SYNE3 interactions	KIDINS220 BRCA2 SAMD4B CCDC138 APC MACF1 NCLN TOP3B PCNT	5.34e-06	444	59	9	int:SYNE3
Interaction	NAV2 interactions	SPTBN1 APC NAV2 TOP3B	7.51e-06	43	59	4	int:NAV2
Interaction	KALRN interactions	DLGAP1 SPTBN1 MACF1 TOP3B PCNT	9.02e-06	96	59	5	int:KALRN
Interaction	RCOR1 interactions	CASP8AP2 HAUS6 ANKFY1 BRCA2 SYNJ1 RABEP1 RABGAP1L APC TNKS1BP1	1.26e-05	494	59	9	int:RCOR1
Interaction	OCLN interactions	ANKFY1 KIDINS220 SPTBN1 APC LMTK2 RDX MACF1 TNKS1BP1 ARL15	1.38e-05	500	59	9	int:OCLN
Interaction	HERC2 interactions	RMI1 RABEP1 CEP162 SPTBN1 MACF1 SIPA1 CLSPN TOP3B PPL	1.45e-05	503	59	9	int:HERC2
Interaction	TOP3B interactions	DDX19B RMI1 SYNJ1 RBM33 SAMD4B OBSCN NAV2 LMTK2 GRB10 TNKS1BP1 MED13L NCLN TOP3B PLXNA1 PCNT	1.53e-05	1470	59	15	int:TOP3B
Interaction	GOLGA1 interactions	ERCC6L CCDC138 APC MACF1 TNKS1BP1 PCNT	1.56e-05	183	59	6	int:GOLGA1
Interaction	ALKBH2 interactions	BRCA2 SYNJ1 LCN1	2.23e-05	19	59	3	int:ALKBH2
Interaction	STK40 interactions	ETV1 ETV5 TNKS1BP1 TOP3B	2.50e-05	58	59	4	int:STK40
Interaction	CCDC138 interactions	CEP162 SAMD4B CCDC138 TRAF3IP3 PCNT	3.00e-05	123	59	5	int:CCDC138
Interaction	RNF43 interactions	HAUS6 KIDINS220 RBM33 OBSCN APC MACF1 TOP3B PPL	3.28e-05	427	59	8	int:RNF43
Interaction	KCNA3 interactions	HAUS6 KIDINS220 ERCC6L SPTBN1 APC GRB10 RDX MACF1 TNKS1BP1 RP1 PPL	3.86e-05	871	59	11	int:KCNA3
Interaction	KRT8 interactions	MYH1 SYNJ1 RABEP1 CEP162 CCDC138 APC PPL PCNT	4.12e-05	441	59	8	int:KRT8
Interaction	PLEKHG1 interactions	MYH13 CEP162 SAMD4B TOP3B	4.42e-05	67	59	4	int:PLEKHG1
Interaction	RPGRIP1L interactions	HAUS6 RABEP1 CEP162 CCDC138 APC PCNT	4.98e-05	225	59	6	int:RPGRIP1L
Interaction	CNOT9 interactions	HAUS6 SAMD4B CCDC138 APC GRB10 TNKS1BP1	5.77e-05	231	59	6	int:CNOT9
Interaction	DUSP16 interactions	HAUS6 BRCA2 ERCC6L CCDC138 TOP3B PCNT	6.65e-05	237	59	6	int:DUSP16
Interaction	KDM1A interactions	CASP8AP2 HAUS6 ANKFY1 BRCA2 SYNJ1 RABEP1 CEP162 RABGAP1L APC TNKS1BP1 PCNT	7.75e-05	941	59	11	int:KDM1A
Interaction	DCTN1 interactions	HAUS6 ANKFY1 CEP162 SPTBN1 CCDC138 APC MACF1 TOP3B	9.50e-05	497	59	8	int:DCTN1
Interaction	PLXND1 interactions	MACF1 TOP3B PLXNA1	1.01e-04	31	59	3	int:PLXND1
Interaction	SASS6 interactions	HAUS6 CEP162 CCDC138 APC PCNT	1.02e-04	159	59	5	int:SASS6
Interaction	TNKS1BP1 interactions	ANKFY1 SPTBN1 RDX TNKS1BP1 TOP3B	1.32e-04	168	59	5	int:TNKS1BP1
Interaction	APC interactions	DLGAP1 SAMD4B SPTBN1 APC NAV2 MACF1 RP1	1.36e-04	389	59	7	int:APC
Interaction	RHOF interactions	DDX19B ANKFY1 KIDINS220 SPTBN1 RDX MACF1 NCLN TOP3B PLXNA1	1.38e-04	673	59	9	int:RHOF
Interaction	CEP135 interactions	HAUS6 BRCA2 CEP162 CCDC138 APC PCNT	1.42e-04	272	59	6	int:CEP135
Interaction	KRT38 interactions	TRIM33 HAUS6 BRCA2 APC PCNT	1.47e-04	172	59	5	int:KRT38
Interaction	SPTBN2 interactions	DLGAP1 SPTBN1 APC TOP3B PCNT	1.47e-04	172	59	5	int:SPTBN2
Interaction	FBXO22 interactions	MYH13 RBM33 SPTBN1 OBSCN NAV2 RP1 NCLN TOP3B	1.68e-04	540	59	8	int:FBXO22
Interaction	SFN interactions	ERCC6L CEP162 RABGAP1L SPTBN1 APC NAV2 LMTK2 GRB10 MACF1	1.70e-04	692	59	9	int:SFN
Interaction	MPHOSPH9 interactions	ANKFY1 CEP162 SAMD4B PCNT	1.73e-04	95	59	4	int:MPHOSPH9
Interaction	SEMA6C interactions	TOP3B PLXNA1	1.75e-04	7	59	2	int:SEMA6C
Interaction	CEP63 interactions	HAUS6 SPTBN1 CCDC138 MACF1 PCNT	1.78e-04	179	59	5	int:CEP63
Interaction	CEP152 interactions	HAUS6 ANKFY1 SAMD4B CCDC138 PCNT	1.78e-04	179	59	5	int:CEP152
Interaction	PPP3CB interactions	PPP1R7 DLGAP1 LMTK2 GRB10	1.95e-04	98	59	4	int:PPP3CB
Interaction	LYN interactions	KIDINS220 SPTBN1 APC LMTK2 RDX MACF1 TNKS1BP1 TOP3B PLXNA1	2.29e-04	720	59	9	int:LYN
Interaction	SYNPO interactions	DLGAP1 CEP162 SPTBN1 APC PPL	2.46e-04	192	59	5	int:SYNPO
Interaction	MINK1 interactions	DLGAP1 ERCC6L TNKS1BP1 TRAF3IP3 ARL15	2.52e-04	193	59	5	int:MINK1
Interaction	AATK interactions	PPP1R7 ANKFY1 RABEP1 RDX TOP3B	2.58e-04	194	59	5	int:AATK
Interaction	NCKAP5L interactions	HAUS6 RABEP1 RABGAP1L APC	2.63e-04	106	59	4	int:NCKAP5L
Interaction	LATS1 interactions	MYH1 ANKFY1 MYH13 SPTBN1 CCDC138 APC PCNT	2.89e-04	440	59	7	int:LATS1
Interaction	CCDC183 interactions	ANKFY1 RABEP1 PCNT	2.90e-04	44	59	3	int:CCDC183
Interaction	TRIO interactions	DLGAP1 ANKFY1 NAV2 TOP3B	2.93e-04	109	59	4	int:TRIO
Interaction	CEP131 interactions	BRCA2 CEP162 SAMD4B TOP3B PCNT	2.97e-04	200	59	5	int:CEP131
Interaction	IQGAP1 interactions	DDX19B TRIM33 MYH1 SPTBN1 APC SIPA1 TOP3B GGPS1	3.10e-04	591	59	8	int:IQGAP1
Interaction	STX6 interactions	ANKFY1 KIDINS220 SYNJ1 RABEP1 SPTBN1 LMTK2 MACF1	3.22e-04	448	59	7	int:STX6
Interaction	MLF1 interactions	HAUS6 BRCA2 ERCC6L RABGAP1L	3.36e-04	113	59	4	int:MLF1
Interaction	TOP3A interactions	RMI1 BRCA2 CEP162 TOP3B	3.48e-04	114	59	4	int:TOP3A
Interaction	MAGEA9 interactions	TRIM33 HAUS6 BRCA2 SYNJ1 TNKS1BP1	3.55e-04	208	59	5	int:MAGEA9
Interaction	NINL interactions	HAUS6 BRCA2 CEP162 CCDC138 LCN1 TOP3B PCNT	3.68e-04	458	59	7	int:NINL
Interaction	YWHAZ interactions	DLGAP1 RABEP1 CEP162 SAMD4B SPTBN1 APC NAV2 GRB10 MACF1 PPFIA3 SIPA1 PCNT	3.72e-04	1319	59	12	int:YWHAZ
Interaction	ZYX interactions	KIDINS220 RABEP1 APC MACF1 TNKS1BP1 PCNT	3.94e-04	329	59	6	int:ZYX
Interaction	CNKSR1 interactions	TRIM33 BRCA2 PPFIA3	3.99e-04	49	59	3	int:CNKSR1
Interaction	CPNE4 interactions	CEP162 SPTBN1 RDX	3.99e-04	49	59	3	int:CPNE4
Interaction	SAMD4B interactions	SAMD4B CCDC138 APC TOP3B	4.50e-04	122	59	4	int:SAMD4B
Interaction	GRAMD2A interactions	TRAF3IP3 TOP3B	4.56e-04	11	59	2	int:GRAMD2A
Interaction	BFSP1 interactions	RABGAP1L NCLN PPL	4.76e-04	52	59	3	int:BFSP1
Interaction	OFD1 interactions	HAUS6 RABEP1 CEP162 CCDC138 TOP3B PCNT	5.21e-04	347	59	6	int:OFD1
Interaction	CTNNA1 interactions	TRIM33 KIDINS220 SPTBN1 APC GRB10 MACF1	5.21e-04	347	59	6	int:CTNNA1
Interaction	CHSY1 interactions	DLGAP1 SLC39A5 TOP3B	5.32e-04	54	59	3	int:CHSY1
Interaction	SHANK2 interactions	DLGAP1 GRB10 TOP3B	5.61e-04	55	59	3	int:SHANK2
Interaction	MAPRE3 interactions	CEP162 APC NAV2 MACF1 PCNT	5.62e-04	230	59	5	int:MAPRE3
Interaction	KCTD13 interactions	PPP1R7 DLGAP1 CACNB2 KIDINS220 SYNJ1 SPTBN1 APC RDX MACF1 TNKS1BP1 PPFIA3 SIPA1	6.12e-04	1394	59	12	int:KCTD13
Interaction	ANKRD28 interactions	TRIM33 ANKFY1 CEP162 APC GRB10	6.20e-04	235	59	5	int:ANKRD28
Interaction	ANKFY1 interactions	ANKFY1 KIDINS220 SYNJ1 TNKS1BP1 PCNT	6.32e-04	236	59	5	int:ANKFY1
Interaction	NPHP4 interactions	SPTBN1 OBSCN LCN1 TOP3B CCIN	6.32e-04	236	59	5	int:NPHP4
Interaction	LRRC7 interactions	DLGAP1 SPTBN1 MACF1	6.56e-04	58	59	3	int:LRRC7
Interaction	OTUD7A interactions	SPTBN1 MACF1 TNKS1BP1	6.56e-04	58	59	3	int:OTUD7A
Interaction	TREX2 interactions	DDX19B BRCA2 PPL	6.56e-04	58	59	3	int:TREX2
Interaction	YWHAB interactions	TRIM33 DLGAP1 RABEP1 CEP162 SAMD4B SPTBN1 APC NAV2 MACF1 SIPA1	6.60e-04	1014	59	10	int:YWHAB
Interaction	SIPA1L2 interactions	ANKFY1 SAMD4B SIPA1 TOP3B	6.77e-04	136	59	4	int:SIPA1L2
Interaction	PACSIN1 interactions	SYNJ1 SPTBN1 APBB1IP	7.24e-04	60	59	3	int:PACSIN1
Interaction	MAPRE1 interactions	CEP162 SPTBN1 CCDC138 APC NAV2 MACF1 PCNT	7.30e-04	514	59	7	int:MAPRE1
Interaction	POLE interactions	BRCA2 CLSPN TOP3B ZBBX	7.35e-04	139	59	4	int:POLE
Interaction	EPB41L4A interactions	KIDINS220 SPTBN1 APC MACF1	7.55e-04	140	59	4	int:EPB41L4A
Interaction	PRKACA interactions	CACNB2 SPTBN1 ETV1 APC RDX TOP3B PCNT	7.73e-04	519	59	7	int:PRKACA
Interaction	CNOT10 interactions	SAMD4B TNKS1BP1 TOP3B PPL	7.75e-04	141	59	4	int:CNOT10
Interaction	EXOC1 interactions	RABEP1 RABGAP1L MACF1 PCNT	8.17e-04	143	59	4	int:EXOC1
Interaction	TUFT1 interactions	HAUS6 RABEP1 RABGAP1L	8.35e-04	63	59	3	int:TUFT1
Interaction	RP1 interactions	APC RP1	8.63e-04	15	59	2	int:RP1
Interaction	FANCM interactions	RMI1 BRCA2 ZBBX	8.75e-04	64	59	3	int:FANCM
Interaction	L1CAM interactions	RDX TOP3B PLXNA1	8.75e-04	64	59	3	int:L1CAM
Interaction	DNAJC6 interactions	DLGAP1 MYH13 PCNT	8.75e-04	64	59	3	int:DNAJC6
Interaction	DCAF15 interactions	TRIM33 RMI1 SYNJ1 CEP162 OBSCN	8.95e-04	255	59	5	int:DCAF15
Interaction	MKRN2 interactions	SYNJ1 CCDC138 APC MACF1 TOP3B PCNT	8.97e-04	385	59	6	int:MKRN2
Interaction	CEP89 interactions	HAUS6 CEP162 SAMD4B CCDC138	9.06e-04	147	59	4	int:CEP89
Interaction	PPP1R3A interactions	PPP1R7 MYH1 LMTK2	9.15e-04	65	59	3	int:PPP1R3A
Interaction	RBSN interactions	MYH1 ANKFY1 MACF1	9.15e-04	65	59	3	int:RBSN
Interaction	FMR1 interactions	DLGAP1 CACNB2 SPTBN1 APC MACF1 TOP3B PCNT	9.33e-04	536	59	7	int:FMR1
Interaction	RAD9A interactions	BRCA2 CLSPN TOP3B	9.57e-04	66	59	3	int:RAD9A
Interaction	ITSN1 interactions	DLGAP1 SYNJ1 RABEP1 SPTBN1 PPL	9.59e-04	259	59	5	int:ITSN1
Interaction	SYNC interactions	RABEP1 APC PPL	9.99e-04	67	59	3	int:SYNC
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	MYH1 ANKFY1 MYH13 RABEP1 FBXO39	9.18e-05	346	60	5	chr17p13
GeneFamily	EF-hand domain containing\|Plakins	MACF1 PPL	1.26e-04	8	39	2	939
GeneFamily	Myosin heavy chains	MYH1 MYH13	4.68e-04	15	39	2	1098
GeneFamily	ETS transcription factor family	ETV1 ETV5	1.65e-03	28	39	2	534
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP	MYH13 OBSCN ETV1 NAV2 GRB10 NCLN TOP3B	3.20e-07	199	59	7	M4978
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	RABGAP1L SPTBN1 GRB10 MACF1 MED13L ARL15	6.55e-07	137	59	6	M39241
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	TRIM33 CASP8AP2 RMI1 HAUS6 KIDINS220 RABEP1 RABGAP1L APC RDX IWS1	1.87e-06	656	59	10	M18979
Coexpression	MARSON_BOUND_BY_E2F4_UNSTIMULATED	PPP1R7 CASP8AP2 HAUS6 ANKFY1 BRCA2 ERCC6L CLSPN PCNT IWS1	2.92e-05	714	59	9	M1744
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	TRIM33 MACF1 TRAF3IP3 MED13L	6.86e-05	97	59	4	M14698
Coexpression	GSE360_CTRL_VS_L_DONOVANI_MAC_DN	TRIM33 ECM2 RABGAP1L MACF1 GGPS1	8.61e-05	199	59	5	M5159
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	TRIM33 HAUS6 RABEP1 NAV2 GRB10 MED13L GGPS1 PPL PDZD2	8.66e-05	822	59	9	M6782
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN	SPTBN1 ETV5 MACF1 TRAF3IP3 ARL15 PLXNA1 PDZD2	1.14e-04	491	59	7	MM455
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TRIM33 KIDINS220 BRCA2 RABGAP1L APC RDX MACF1 MED13L PCNT	1.18e-04	856	59	9	M4500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	CASP8AP2 CACNB2 HAUS6 BRCA2 ERCC6L RABEP1 CCDC138 ETV1 APC RDX MACF1 CLSPN IWS1	2.67e-05	1257	58	13	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	DDX19B CASP8AP2 RMI1 CACNB2 BRCA2 SYNJ1 CCDC149 CEP162 CCDC138 ETV1 APC CLSPN TOP3B	6.52e-05	1370	58	13	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	PPP1R7 CASP8AP2 HAUS6 BRCA2 RABEP1 CLSPN PCNT IWS1	9.39e-05	532	58	8	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	CASP8AP2 CACNB2 HAUS6 BRCA2 ERCC6L RABEP1 CCDC138 ETV1 APC RDX MACF1 CLSPN IWS1	1.23e-04	1459	58	13	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	CASP8AP2 BRCA2 RABEP1 CLSPN IWS1	1.78e-04	192	58	5	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	CASP8AP2 BRCA2 RABEP1 CEP162 CLSPN IWS1	2.01e-04	311	58	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	RABGAP1L GRB10 MACF1 MED13L ARL15 PDZD2	2.31e-07	192	60	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	SPTBN1 NAV2 MACF1 RP1 CLSPN ZBBX	2.61e-07	196	60	6	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	SPTBN1 NAV2 MACF1 RP1 CLSPN ZBBX	2.61e-07	196	60	6	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	ASK454-Epithelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	NAV2 RDX RP1 PLXNA1 PPL	4.68e-06	182	60	5	ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CACNB2 RABGAP1L OBSCN ETV1 PDZD2	5.06e-06	185	60	5	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPTBN1 NAV2 LMTK2 RP1 PDZD2	5.76e-06	190	60	5	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	BRCA2 ERCC6L SPTBN1 NAV2 CLSPN	6.22e-06	193	60	5	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	RABGAP1L NAV2 MED13L ARL15 PDZD2	6.70e-06	196	60	5	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	RABGAP1L NAV2 MED13L ARL15 PDZD2	7.04e-06	198	60	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	CCDC138 ETV1 GRB10 PDZD2 ZBBX	7.39e-06	200	60	5	401d50fa394fa863fa7836344110ae5c7af3250a
ToppCell	15-Trachea-Immune-Immune\|Trachea / Age, Tissue, Lineage and Cell class	BRCA2 CLSPN NLRC4 APBB1IP	4.51e-05	146	60	4	ca722a89c6601e78f253d9484d01931f26161820
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH13 OBSCN ETV1 PDZD2	7.08e-05	164	60	4	a764b79a127c8f360af0b79a1da64658badf0dfa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CASP8AP2 RMI1 BRCA2 CLSPN	7.95e-05	169	60	4	e7514956b2e4298222ec443f98b2f5289451786e
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RMI1 HAUS6 ERCC6L CLSPN	8.13e-05	170	60	4	b62f7184e78e9672ea88e361654f604f9df2dc5f
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RMI1 HAUS6 ERCC6L CLSPN	8.13e-05	170	60	4	00fe77bca9c28762212c498f9c49e14cb1492cca
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	SPTBN1 NAV2 RP1 PDZD2	8.13e-05	170	60	4	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	5'-Adult-LargeIntestine-Epithelial-neuro-epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNB2 LMX1A ETV1 ZBBX	8.90e-05	174	60	4	9f114e61458659005b6d0b4aa30a7a059e7aa5c6
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	SPTBN1 NAV2 RP1 PDZD2	8.90e-05	174	60	4	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAUS6 TOP3B PPL PDZD2	9.30e-05	176	60	4	27e5115fae5f0f63b333bc99fbf6a6d4c9182c46
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANKFY1 BRCA2 SIPA1 NLRC4	9.93e-05	179	60	4	06d412fc096d88de168969466ce422f0ab5553b2
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	CACNB2 RABGAP1L OBSCN PDZD2	1.10e-04	184	60	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPTBN1 NAV2 RP1 PDZD2	1.13e-04	185	60	4	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	URO-Lymphocyte-T_NK-T_NK_proliferative\|URO / Disease, Lineage and Cell Type	BRCA2 ERCC6L ETV1 CLSPN	1.13e-04	185	60	4	0ae9c646679c69a553eda670aef0e0495feb0286
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	ANKFY1 KIDINS220 MACF1 ARL15	1.13e-04	185	60	4	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	Mild_COVID-19-Epithelial-AT1/AT2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CACNB2 ETV1 NAV2 PDZD2	1.13e-04	185	60	4	c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	ANKFY1 KIDINS220 MACF1 ARL15	1.15e-04	186	60	4	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP1 ETV1 NAV2 ETV5	1.15e-04	186	60	4	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TRIM33 CASP8AP2 APC IWS1	1.15e-04	186	60	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	PND03\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTBN1 APC NAV2 APBB1IP	1.17e-04	187	60	4	b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRCA2 ERCC6L NAV2 CLSPN	1.22e-04	189	60	4	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	NS-critical-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RMI1 BRCA2 ERCC6L PCNT	1.25e-04	190	60	4	7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	CACNB2 RABGAP1L OBSCN PDZD2	1.25e-04	190	60	4	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CACNB2 ETV1 NAV2 MACF1	1.25e-04	190	60	4	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RMI1 BRCA2 ERCC6L PCNT	1.25e-04	190	60	4	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	ECM2 SPTBN1 ETV1 MACF1	1.25e-04	190	60	4	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	CACNB2 RABGAP1L OBSCN PDZD2	1.27e-04	191	60	4	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	ANKFY1 KIDINS220 MACF1 ARL15	1.27e-04	191	60	4	9454f642c3621370fa23640b631301346b300950
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	DLGAP1 RBM33 MED13L ARL15	1.30e-04	192	60	4	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DLGAP1 CACNB2 NAV2 MACF1	1.33e-04	193	60	4	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	DLGAP1 CACNB2 ETV1 MACF1	1.33e-04	193	60	4	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	DLGAP1 RBM33 MED13L ARL15	1.33e-04	193	60	4	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PSB-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RMI1 BRCA2 ERCC6L PCNT	1.33e-04	193	60	4	b7d9c5bed524423e92f01496a9f8fad11b33a3f7
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RMI1 BRCA2 ERCC6L SPTBN1	1.35e-04	194	60	4	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ETV1 LMTK2 ETV5 PDZD2	1.35e-04	194	60	4	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	CACNB2 RABGAP1L OBSCN PDZD2	1.35e-04	194	60	4	c3535f7cc0076653c72db582047cff053c322397
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RMI1 BRCA2 ERCC6L PCNT	1.35e-04	194	60	4	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	SPTBN1 NAV2 RP1 ZBBX	1.38e-04	195	60	4	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SPTBN1 OBSCN MACF1 TRAF3IP3	1.38e-04	195	60	4	4bdedd924564a260841a9153604026b57487c83d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SPTBN1 ETV1 ETV5 MACF1	1.38e-04	195	60	4	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APC ETV5 MACF1 APBB1IP	1.38e-04	195	60	4	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	SPTBN1 NAV2 RP1 ZBBX	1.38e-04	195	60	4	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA2 ERCC6L NAV2 CLSPN	1.44e-04	197	60	4	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / Treatment groups by lineage, cell group, cell type	BRCA2 ERCC6L NAV2 RP1	1.44e-04	197	60	4	038fd92750257d43d5e980fd06d77742b543f11a
ToppCell	critical-Epithelial-FOXN4+\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RMI1 BRCA2 ERCC6L PCNT	1.46e-04	198	60	4	6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	TRIM33 RABEP1 CEP162 IWS1	1.46e-04	198	60	4	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	KIDINS220 SPTBN1 RDX MACF1	1.49e-04	199	60	4	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	Transverse-T_cell-Tfh\|Transverse / Region, Cell class and subclass	DLGAP1 RABGAP1L OBSCN PLXNA1	1.49e-04	199	60	4	cbef8f95edf2e86e16c448a76068d7ed8f6b7748
ToppCell	Transverse-(1)_T_cell-(16)_Tfh\|Transverse / shred on region, Cell_type, and subtype	DLGAP1 RABGAP1L OBSCN PLXNA1	1.49e-04	199	60	4	aa31e26d48066f865ca33251a33a28934c0a7a44
ToppCell	Transverse-T_cell-Tfh\|T_cell / Region, Cell class and subclass	DLGAP1 RABGAP1L OBSCN PLXNA1	1.49e-04	199	60	4	33ffea12b8228e0b5bd8942531c3b21d24224725
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	BRCA2 ERCC6L NAV2 CLSPN	1.49e-04	199	60	4	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BRCA2 ERCC6L NAV2 CLSPN	1.49e-04	199	60	4	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIDINS220 SPTBN1 RDX MACF1	1.52e-04	200	60	4	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPTBN1 RDX MACF1 PCNT	1.52e-04	200	60	4	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	BRCA2 ERCC6L NAV2 CLSPN	1.52e-04	200	60	4	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	ETV1 ETV5 RDX CLSPN	1.52e-04	200	60	4	474e6ab48f199315f3cca86b81fdf54e0461b7b8
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIDINS220 SPTBN1 RDX MACF1	1.52e-04	200	60	4	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIDINS220 SPTBN1 RDX MACF1	1.52e-04	200	60	4	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	critical-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RMI1 BRCA2 ERCC6L PCNT	1.52e-04	200	60	4	f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells-Stem_cells\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	ETV1 ETV5 RDX CLSPN	1.52e-04	200	60	4	01a29651e9bb64ef7666c6a61ec396eeb88b2816
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A	KIDINS220 BRCA2 RABEP1 CEP162 SPTBN1 ETV1 APC	6.63e-07	193	59	7	6716_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RABEP1 RABGAP1L SPTBN1 APC PPFIA3 TOP3B	1.03e-05	192	59	6	6025_DN
Drug	Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A	KIDINS220 CEP162 RABGAP1L MED13L GGPS1 PLXNA1	1.16e-05	196	59	6	7222_DN
Drug	Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A	PPP1R7 TRIM33 ANKFY1 RABEP1 ETV1 PPL	1.20e-05	197	59	6	5087_DN
Drug	Pirenperone [ 75444-65-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	PPP1R7 BRCA2 RABEP1 RABGAP1L SPTBN1 ARL15	1.20e-05	197	59	6	4679_DN
Drug	Sparteine (-) [90-39-1]; Up 200; 17uM; PC3; HT_HG-U133A	PPP1R7 RABGAP1L SAMD4B SPTBN1 ETV1 APC	1.27e-05	199	59	6	4568_UP
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A	KIDINS220 SPTBN1 APC LMTK2 GRB10 SIPA1	1.27e-05	199	59	6	6521_UP
Drug	AC1N9ZZC	MYH1 MYH13 SYNJ1 OBSCN NAV2	4.23e-05	149	59	5	CID004369374
Drug	Cycloheximide [66-81-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A	ERCC6L RABEP1 CEP162 GRB10 MACF1	7.69e-05	169	59	5	3464_DN
Drug	pararosaniline base; Up 200; 10uM; MCF7; HT_HG-U133A_EA	NAV2 ETV5 GRB10 PPFIA3 MED13L	9.56e-05	177	59	5	893_UP
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	ANKFY1 RABEP1 APC MACF1 PLXNA1	9.56e-05	177	59	5	4652_DN
Drug	pcon	PPL PDZD2	9.84e-05	6	59	2	CID000006979
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	TRIM33 BRCA2 SYNJ1 ERCC6L MED13L	1.09e-04	182	59	5	3887_DN
Drug	5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA	CEP162 RABGAP1L ETV5 MED13L ARL15	1.18e-04	185	59	5	944_UP
Drug	Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A	CACNB2 ANKFY1 SPTBN1 APC GRB10	1.47e-04	194	59	5	5342_UP
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	RABEP1 NAV2 ETV5 GGPS1 PDZD2	1.47e-04	194	59	5	4662_DN
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A	ANKFY1 RABEP1 CEP162 SPTBN1 ETV5	1.47e-04	194	59	5	4391_DN
Drug	Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A	KIDINS220 SPTBN1 APC MACF1 PPFIA3	1.47e-04	194	59	5	3521_DN
Drug	Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A	CEP162 SPTBN1 APC PLXNA1 PDZD2	1.51e-04	195	59	5	6259_UP
Drug	0173570-0000 [211245-44-2]; Down 200; 10uM; MCF7; HT_HG-U133A	CEP162 SPTBN1 APC GGPS1 PLXNA1	1.51e-04	195	59	5	4712_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	ANKFY1 KIDINS220 BRCA2 CEP162 SPTBN1	1.51e-04	195	59	5	3721_DN
Drug	Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; PC3; HT_HG-U133A	KIDINS220 BRCA2 SAMD4B APC TOP3B	1.51e-04	195	59	5	6718_UP
Drug	Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A	ETV5 RDX MED13L NCLN PLXNA1	1.51e-04	195	59	5	2004_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	TRIM33 ANKFY1 RABEP1 SPTBN1 ETV1	1.51e-04	195	59	5	3755_DN
Drug	Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A	KIDINS220 APC NAV2 PPFIA3 ARL15	1.54e-04	196	59	5	3271_DN
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	ANKFY1 SPTBN1 ETV1 APC TOP3B	1.54e-04	196	59	5	7495_DN
Drug	Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	ANKFY1 KIDINS220 CEP162 RABGAP1L SIPA1	1.54e-04	196	59	5	6605_DN
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	CACNB2 ANKFY1 APC PPFIA3 PLXNA1	1.54e-04	196	59	5	3568_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	PPP1R7 BRCA2 RABEP1 SPTBN1 ETV1	1.54e-04	196	59	5	6708_DN
Drug	Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; PC3; HT_HG-U133A	ANKFY1 SPTBN1 ETV1 APC PPL	1.58e-04	197	59	5	4233_DN
Drug	Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ANKFY1 RABEP1 RABGAP1L GRB10 ARL15	1.58e-04	197	59	5	3425_DN
Drug	Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A	RABEP1 CEP162 APC GRB10 TOP3B	1.58e-04	197	59	5	3372_DN
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A	KIDINS220 CEP162 SPTBN1 APC PPFIA3	1.58e-04	197	59	5	3532_DN
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A	SYNJ1 CEP162 APC PPFIA3 TOP3B	1.62e-04	198	59	5	5622_DN
Drug	Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A	ANKFY1 KIDINS220 APC MACF1 ARL15	1.62e-04	198	59	5	7416_DN
Drug	Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A	ANKFY1 KIDINS220 CEP162 SPTBN1 TOP3B	1.62e-04	198	59	5	6467_UP
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	KIDINS220 SYNJ1 RABGAP1L SPTBN1 APC	1.62e-04	198	59	5	2644_UP
Drug	Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A	SYNJ1 RABEP1 ECM2 SPTBN1 PDZD2	1.62e-04	198	59	5	5515_UP
Drug	Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	RABEP1 RABGAP1L APC PPFIA3 NCLN	1.62e-04	198	59	5	7032_DN
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	RABGAP1L GRB10 ARL15 NCLN PLXNA1	1.66e-04	199	59	5	7203_DN
Drug	Aminocaproic acid [60-32-2]; Down 200; 30.4uM; PC3; HT_HG-U133A	ANKFY1 BRCA2 SYNJ1 APC PPFIA3	1.66e-04	199	59	5	7258_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	RABEP1 APC ETV5 ARL15 APBB1IP	1.66e-04	199	59	5	2683_DN
Drug	Cimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A	PPP1R7 BRCA2 SPTBN1 RDX PLXNA1	1.66e-04	199	59	5	1964_UP
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	ANKFY1 SPTBN1 ETV5 GRB10 PDZD2	1.66e-04	199	59	5	7254_DN
Drug	(-)-quinpirole hydrochloride; Down 200; 1uM; MCF7; HG-U133A	PPP1R7 ECM2 ETV1 ETV5 PLXNA1	1.66e-04	199	59	5	456_DN
Drug	Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A	BRCA2 ETV1 APC ETV5 PPFIA3	1.66e-04	199	59	5	7384_UP
Drug	Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	CEP162 RABGAP1L APC PPFIA3 PLXNA1	1.66e-04	199	59	5	2744_DN
Drug	S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A	DLGAP1 SPTBN1 TRAF3IP3 PPFIA3 PDZD2	1.66e-04	199	59	5	6459_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A	SAMD4B SPTBN1 NAV2 LMTK2 PDZD2	1.66e-04	199	59	5	6182_UP
Drug	Piracetam [7491-74-9]; Down 200; 28.2uM; PC3; HT_HG-U133A	KIDINS220 RABEP1 SPTBN1 MED13L PDZD2	1.69e-04	200	59	5	5043_DN
Drug	4-epidoxorubicin	DDX19B MYH1 KIDINS220 MYH13 BRCA2 SPTBN1 TOP3B CCIN PLXNA1	1.81e-04	788	59	9	CID000001690
Drug	ABT-773	SPTBN1 ETV5	1.83e-04	8	59	2	CID000447451
Disease	odorant-binding protein 2b measurement	LCN1 LCN1P1	3.92e-05	5	59	2	EFO_0801859
Disease	bipolar disorder (implicated_via_orthology)	ETV1 ETV5	8.20e-05	7	59	2	DOID:3312 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH13	1.75e-04	10	59	2	DOID:0110454 (implicated_via_orthology)
Disease	medulloblastoma (is_implicated_in)	BRCA2 APC	1.75e-04	10	59	2	DOID:0050902 (is_implicated_in)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH13	1.75e-04	10	59	2	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH13	1.75e-04	10	59	2	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH13	1.75e-04	10	59	2	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH13	1.75e-04	10	59	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH13	1.75e-04	10	59	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH13	1.75e-04	10	59	2	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH13	1.75e-04	10	59	2	DOID:0111596 (implicated_via_orthology)
Disease	urate measurement, bone density	PPP1R7 CASP8AP2 KIDINS220 RABGAP1L ETV1 PPL PDZD2	2.29e-04	619	59	7	EFO_0003923, EFO_0004531
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH13	2.56e-04	12	59	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH13	2.56e-04	12	59	2	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH13	3.02e-04	13	59	2	DOID:397 (implicated_via_orthology)
Disease	Benign tumor of pancreas	BRCA2 APC	3.02e-04	13	59	2	C0347284
Disease	hearing loss	LMX1A SPTBN1 GRB10	3.32e-04	67	59	3	EFO_0004238
Disease	neutrophil count	TRIM33 KIDINS220 LMX1A RABEP1 RABGAP1L SPTBN1 RP1 TRAF3IP3 NCLN PCNT	3.80e-04	1382	59	10	EFO_0004833
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH13	4.06e-04	15	59	2	DOID:0050646 (implicated_via_orthology)
Disease	body mass index, high density lipoprotein cholesterol measurement	ETV5 ARL15	6.58e-04	19	59	2	EFO_0004340, EFO_0004612
Disease	Pancreatic carcinoma	BRCA2 APC	6.58e-04	19	59	2	C0235974
Disease	alcoholic pancreatitis	KIDINS220 ARL15 PLXNA1	1.01e-03	98	59	3	EFO_1002013
Disease	breast cancer (implicated_via_orthology)	BRCA2 APC	1.14e-03	25	59	2	DOID:1612 (implicated_via_orthology)
Disease	amygdala volume change measurement, age at assessment	ARL15 APBB1IP	1.24e-03	26	59	2	EFO_0008007, EFO_0021490
Disease	Prostatic Neoplasms	BRCA2 ETV1 APC LMTK2 ETV5 PPL	1.42e-03	616	59	6	C0033578
Disease	Malignant neoplasm of prostate	BRCA2 ETV1 APC LMTK2 ETV5 PPL	1.42e-03	616	59	6	C0376358
Disease	upper aerodigestive tract neoplasm	BRCA2 ARL15 APBB1IP IWS1	1.50e-03	246	59	4	EFO_0004284
Disease	Schizophrenia	DLGAP1 CACNB2 LMX1A APC GRB10 TOP3B PCNT	1.85e-03	883	59	7	C0036341

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSEDDLEAARNELHS	ARL15	111	Q9NXU5
DENLHVLNEDQALSA	CCIN	186	Q13939
DLNESLNALEDQDLD	APBB1IP	51	Q7Z5R6
QADLDFHDNLENSLE	DLGAP1	701	O14490
FHDNLENSLESIEDN	DLGAP1	706	O14490
HDDDNSVLSIDLNHL	CASP8AP2	836	Q9UKL3
LDENQLEDACEHLAD	CACNB2	441	Q08289
DLSDEELNDDLLQSD	RBM33	61	Q96EV2
ESSAQLSNEEEHLDS	RABEP1	356	Q15276
SDSENEELLNGHASD	IWS1	131	Q96ST2
DNLDHTDSSLLQDNV	NCLN	291	Q969V3
HDEHDENNAEASAEL	RDX	486	P35241
EADHNGDLALDLALS	ANKFY1	251	Q9P2R3
NHSLHNEVADDSQLE	KIDINS220	1596	Q9ULH0
SLHDLDNIFDNSDDD	MED13L	806	Q71F56
HQTSEGDLDDLAQDL	NLRC4	91	Q9NPP4
SLHDANDKLENELAS	PPFIA3	321	O75145
LQAHHLLASDEEIQD	LCN1P1	16	Q5VSP4
AELQTDIHELTNDLD	PLXNA1	1301	Q9UIW2
HDLDSDDTSLSNLGD	LMX1A	336	Q8TE12
ELLATHENHLNQDDT	PPL	626	O60437
VLENLHISESQDLDD	PDZD2	1771	O15018
NRDLAHDSEELFQDL	ETV1	36	P50549
HDSEELFQDLSQLQE	ETV1	41	P50549
EFNNNHESLDEELHL	FBXO39	346	Q8N4B4
DAESHLDSELEISND	MACF1	2696	O94854
LQAHHLLASDEEIQD	LCN1	16	P31025
SDDSDEDLRAFNLHS	LMTK2	1291	Q8IWU2
DTDLAHDSEELFQDL	ETV5	36	P41161
HDSEELFQDLSQLQE	ETV5	41	P41161
LHNASLLIDDIEDNS	GGPS1	56	O95749
DTQLHLDDALRSQED	MYH1	1656	P12882
LQQLEQDLTSDDALH	PCNT	821	O95613
DHNTSLSRLEDLLQD	MACF1	816	Q9UPN3
LEQENDDLAHELVTS	RABGAP1L	26	B7ZAP0
HEEAQLLAELSDQAA	OBSCN	721	Q5VST9
NVNCLDDELDSFHDL	CCDC138	86	Q96M89
SLEHDLQASVDELQD	CCDC149	111	Q6ZUS6
ALDDSEDILHNSLDN	BRCA2	1896	P51587
EDILHNSLDNDECST	BRCA2	1901	P51587
DEQEAAAESLSNLHL	DDX19B	11	Q9UMR2
LHSNQANAELTDDEH	CEP162	166	Q5TB80
EDDDSNLEHLHLENN	ECM2	656	O94769
DDTLNFLDTCDLHTE	HAUS6	876	Q7Z4H7
RLANHQEDDVDLEAL	GRB10	41	Q13322
TNHDQCLLDEDQALE	DCAF8L1	126	A6NGE4
TINLDRDAEDVDLNH	PPP1R7	71	Q15435
EIADDLSASHSALQD	ERCC6L	916	Q2NKX8
NISELESFEELENHD	RP1	1461	P56715
NLHLESELDALASLE	TRIM33	821	Q9UPN9
AEDLDLLNASFQDES	SYNJ1	821	O43426
ELLASLDENDELTAN	RMI1	246	Q9H9A7
NSNSHHDDILDSSLE	NAV2	2471	Q8IVL1
LASAEDQAASSDLLH	SIPA1	146	Q96FS4
LDHSLADHLNEDCLN	SLC39A5	146	Q6ZMH5
EEASLLHQFQADADD	SPTBN1	741	Q01082
EAELDAQHLSETFDN	APC	761	P25054
LFHRDSDDDQTEEQL	CLSPN	1151	Q9HAW4
DHNEALSVDARQELD	TOP3B	171	O95985
ELHSELDNLSDEYLS	TRAF3IP3	486	Q9Y228
DCNDIHLLESEANSA	SAMD4B	51	Q5PRF9
LSEAADSDAHLFQDS	TNKS1BP1	1596	Q9C0C2
DSQLHLDDALRSNED	MYH13	1656	Q9UKX3
AADLLSALSQEEQDL	UBAP1L	261	F5GYI3
ELSLDDTTDQHTLDN	ZBBX	686	A8MT70